This biotech company designs gold nanoparticles for cancer therapy using green chemistry and non-toxic nanomaterials. Their approach targets both surface and deep cancers, providing healthcare providers with eco-friendly treatment options that enhance patient care.
Funding
$270K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional cancer treatments often involve harsh chemicals and can lack precision, leading to significant side effects and damage to healthy tissues. There is a need for more targeted and biocompatible therapeutic approaches that minimize harm to the patient.
Solution
Torskal develops gold nanoparticles designed for targeted cancer therapy, utilizing a green chemistry approach with non-toxic nanomaterials. These nanoparticles can be customized in size and surface properties for specific applications, including nanotheranostics and deep cancer treatments. The company's products aim to provide healthcare providers with eco-friendly and customizable treatment options that enhance patient care by targeting both surface and deep-seated cancers.
Target Audience
The primary customers are researchers and healthcare providers in oncology seeking advanced nanomaterials for cancer therapy and diagnostics.
Features
- Spherical gold nanoparticles available in various sizes (12nm, 15nm, 16nm, 17nm, 25nm, 35nm, 40nm).
- Gold nanoflowers with a size of 15nm.
- Customizable nanoparticle properties for specific targeting and drug delivery.
- Nanotheranostics project (NT1) focused on combining diagnostics and therapeutics.
- Deep Cancer Project (NT2) targeting cancers in deeper tissues.
- Green synthesis methods to ensure biocompatibility and reduce toxicity.